Similar Papers

Paper Title
Journal
Date
Author
Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up
...
The Lancet | VOL. 359
, et. al. ...
01 Apr 2002
Long-Term Effectiveness and Safety of Pravastatin in 9014 Patients With Coronary Heart Disease and Average Cholesterol Concentrations: The Lipid Trial Follow-Up
-
Obstetrical & Gynecological Survey | VOL. 57
--
01 Nov 2002
Long-Term Effectiveness and Safety of Pravastatin in Patients With Coronary Heart Disease: Sixteen Years of Follow-Up of the LIPID Study.
Wendy E Hague ... David M Colquhoun
Circulation | VOL. 133
Wendy E Hague, et. al.Wendy E Hague ... David M Colquhoun
10 May 2016
Letter by Koh Regarding Article, "Long-Term Effectiveness and Safety of Pravastatin in Patients With Coronary Heart Disease: 16 Years of Follow-Up of the LIPID Study".
Kwang Kon Koh
Circulation | VOL. 134
Kwang Kon KohKwang Kon Koh
26 Sep 2016
View more papers

More From: ACC Current Journal Review

Paper Title
Journal
Date
Author
Electrocardiographic Damage Scores and Cardiovascular Mortality
K Richardson ... T Yamazaki
ACC Current Journal Review | VOL. 14
K Richardson, et. al.K Richardson ... T Yamazaki
01 Dec 2005
Low HDL Cholesterol Levels
M Ashen ... R.S Blumenthal
ACC Current Journal Review | VOL. 14
M Ashen, et. al.M Ashen ... R.S Blumenthal
01 Dec 2005
Glomerular Filtration Rate Is Superior to Serum Creatinine for Prediction of Mortality After Thoracoabdominal Aortic Surgery
T.T.T Huynh ... C.C Miller
ACC Current Journal Review | VOL. 14
T.T.T Huynh, et. al.T.T.T Huynh ... C.C Miller
01 Dec 2005
Pioglitazone Decreases Carotid Intima-Media Thickness Independently of Glycemic Control in Patients With Type 2 Diabetes Mellitus: Results From a Controlled Randomized Study
M.R Langenfeld ... C Hohberg
ACC Current Journal Review | VOL. 14
M.R Langenfeld, et. al.M.R Langenfeld ... C Hohberg
01 Dec 2005
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.